RecruitingNot ApplicableNCT04664686

Rate or Rhythm Control in CRT: the RHYTHMIC Study


Sponsor

Guy's and St Thomas' NHS Foundation Trust

Enrollment

70 participants

Start Date

Oct 19, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

70 patients with heart failure, AF and CRT with BiV\<95% will be randomised to either AF ablation or AV node ablation. Evaluation at 6 months with echocardiography and clinical assessment.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria5

  • Ability to provide informed consent to participate and willing to comply with the clinical investigation plan and follow-up schedule.
  • QRS duration \>120ms on surface ECG, severe left ventricular systolic impairment (EF≤35%) and clinical symptoms of heart failure despite optimum medical therapy (NYHA class II-IV) at time of CRT implant or upgrade
  • Successful CRT implant or upgrade including atrial lead
  • Biventricular pacing percentage \<95% secondary to atrial fibrillation at least 3 months post implant or upgrade
  • Clinically indicated for AV node ablation

Exclusion Criteria7

  • Life expectancy \<1 year
  • Presence of atrial or ventricular thrombus
  • Permanent atrial fibrillation
  • Mechanical aortic valve replacement
  • Severe peripheral vascular disease
  • Female participants who are pregnant, lactating or planning pregnancy during the course of the study.
  • Participation in other studies with active treatment / investigational arm

Interventions

PROCEDUREAF catheter ablation

Isolation of all four pulmonary veins and additional lesions, considered indicated by the operator

PROCEDUREAV node ablation

AV node ablation


Locations(1)

Guys and St Thomas' NHS Foundation Trust

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04664686


Related Trials